Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus

Cardiovascular disease is the major cause of mortality among patients with the autoimmune disorder systemic lupus erythematosus (SLE). Our laboratory previously reported that immunosuppression with mycophenolate mofetil, a common therapy in patients with SLE, attenuates the development of hypertensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Victoria L., Taylor, Erin B., Ryan, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533177/
https://www.ncbi.nlm.nih.gov/pubmed/31124322
http://dx.doi.org/10.14814/phy2.14059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533177/
https://www.ncbi.nlm.nih.gov/pubmed/31124322
http://dx.doi.org/10.14814/phy2.14059

Ejemplares similares